BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36297316)

  • 1.
    Yang X; Wang L; Zeng J; Wu A; Qin M; Wen M; Zhang T; Chen W; Mei Q; Qin D; Yang J; Jiang Y; Wu J
    Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Antithrombocytopenia Agent,
    Chen W; Zhu L; Wang L; Zeng J; Wen M; Xu X; Zou L; Huang F; Huang Q; Qin D; Mei Q; Yang J; Wang Q; Wu J
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of machine learning and transcriptomics reveals a novel megakaryopoiesis inducer, MO-A, that promotes thrombopoiesis by activating FGF1/FGFR1/PI3K/Akt/NF-κB signaling.
    Zhang T; Mo Q; Jiang N; Wu Y; Yang X; Chen W; Li Q; Yang S; Yang J; Zeng J; Huang F; Huang Q; Luo J; Wu J; Wang L
    Eur J Pharmacol; 2023 Apr; 944():175604. PubMed ID: 36804544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a novel megakaryopoiesis enhancer, ingenol, promoting thrombopoiesis through PI3K-Akt signaling independent of thrombopoietin.
    Wang L; Zhang T; Liu S; Mo Q; Jiang N; Chen Q; Yang J; Han YW; Chen JP; Huang FH; Li H; Zhou J; Luo JS; Wu JM
    Pharmacol Res; 2022 Mar; 177():106096. PubMed ID: 35077844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hirsutine, a novel megakaryopoiesis inducer, promotes thrombopoiesis via MEK/ERK/FOG1/TAL1 signaling.
    Kang Y; Lin J; Wang L; Shen X; Li J; Wu A; Yue L; Wei L; Ye Y; Yang J; Wu J
    Phytomedicine; 2022 Jul; 102():154150. PubMed ID: 35569185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M2 macrophages, but not M1 macrophages, support megakaryopoiesis by upregulating PI3K-AKT pathway activity.
    Zhao HY; Zhang YY; Xing T; Tang SQ; Wen Q; Lyu ZS; Lv M; Wang Y; Xu LP; Zhang XH; Kong Y; Huang XJ
    Signal Transduct Target Ther; 2021 Jun; 6(1):234. PubMed ID: 34140465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xanthotoxin, a novel inducer of platelet formation, promotes thrombocytopoiesis via IL-1R1 and MEK/ERK signaling.
    Lai J; Li Y; Ran M; Huang Q; Huang F; Zhu L; Wu Y; Zou W; Xie X; Tang Y; Yang F; Wu A; Ge G; Wu J
    Biomed Pharmacother; 2023 Jul; 163():114811. PubMed ID: 37156117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel chemical-structure TPOR agonist, TMEA, promotes megakaryocytes differentiation and thrombopoiesis via mTOR and ERK signalings.
    Jiang X; Sun Y; Yang S; Wu Y; Wang L; Zou W; Jiang N; Chen J; Han Y; Huang C; Wu A; Zhang C; Wu J
    Phytomedicine; 2023 Feb; 110():154637. PubMed ID: 36610353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assessment on Polygoni Multiflori Caulis using HPLC/UV/MS combined with principle component analysis.
    Zhao Y; Kao CP; Chang YS; Ho YL
    Chem Cent J; 2013 Jun; 7(1):106. PubMed ID: 23800018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia.
    Zhou L; Ni C; Liao R; Tang X; Yi T; Ran M; Huang M; Liao R; Zhou X; Qin D; Wang L; Huang F; Xie X; Wan Y; Luo J; Wang Y; Wu J
    Elife; 2024 Apr; 13():. PubMed ID: 38573820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis on medication rules of state medical master yan zhenghua's prescriptions that including Polygoni Multiflori Caulis based on data mining].
    Wu JR; Guo WX; Zhang XM; Yang B; Zhang B; Zhao MD; Sheng XG
    Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(22):4464-9. PubMed ID: 25850286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Characterization of the major chemical constituents from Polygoni Multiflori Caulis by liquid chromatography tandem mass spectrometry and comparative analysis with Polygoni Multiflori Radix.
    Wang GY; Shang J; Wu Y; Ding G; Xiao W
    J Sep Sci; 2017 May; 40(10):2107-2116. PubMed ID: 28322504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEAR1 attenuates megakaryopoiesis via control of the PI3K/PTEN pathway.
    Kauskot A; Vandenbriele C; Louwette S; Gijsbers R; Tousseyn T; Freson K; Verhamme P; Hoylaerts MF
    Blood; 2013 Jun; 121(26):5208-17. PubMed ID: 23667054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-O, 3-O desulfated heparin mitigates murine chemotherapy- and radiation-induced thrombocytopenia.
    Tkaczynski E; Arulselvan A; Tkaczynski J; Avery S; Xiao L; Torok-Storb B; Abrams K; Rao NV; Johnson G; Kennedy TP; Poncz M; Lambert MP
    Blood Adv; 2018 Apr; 2(7):754-761. PubMed ID: 29599195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.
    Yuen HF; Chan KK; Grills C; Murray JT; Platt-Higgins A; Eldin OS; O'Byrne K; Janne P; Fennell DA; Johnston PG; Rudland PS; El-Tanani M
    Clin Cancer Res; 2012 Jan; 18(2):380-91. PubMed ID: 22090358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis.
    Khodadi E; Asnafi AA; Shahrabi S; Shahjahani M; Saki N
    Ann Hematol; 2016 Oct; 95(11):1765-76. PubMed ID: 27236577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGF/EGFR Promotes Salivary Adenoid Cystic Carcinoma Cell Malignant Neural Invasion
    Ren Y; Hong Y; He W; Liu Y; Chen W; Wen S; Sun M
    Curr Cancer Drug Targets; 2022; 22(7):603-616. PubMed ID: 35410600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylinositol 3-Kinase/Akt and MEK/ERK Signaling Pathways Facilitate Sapovirus Trafficking and Late Endosomal Acidification for Viral Uncoating in LLC-PK Cells.
    Soliman M; Kim DS; Park JG; Kim JY; Alfajaro MM; Baek YB; Cho EH; Park CH; Kang MI; Park SI; Cho KO
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30282712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. San Pian decoction can treat nitroglycerin-induced migraine in rats by inhibiting the PI3K/AKT and MAPK signaling pathways.
    Mao Q; Cui Y; Du H; Wu J; Zhou M; Ouyang H; Feng Y; Yang S
    J Ethnopharmacol; 2022 Oct; 296():115470. PubMed ID: 35738471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.